Skip to main content
Premium Trial:

Request an Annual Quote

VA to Use Cepheid's Pathogen Tests in Hospitals

NEW YORK (GenomeWeb News) - Cepheid has inked two contracts with the Veterans Affairs Federal Supply Service Schedule to supply VA hospitals with its pathogen tests and its GeneXpert systems, and another with a Veteran's hospital chain in the northern Midwest, the company said today.
Under the Federal Supply agreements, Cepheid will supply its GeneXpert systems and its methicillin-resistant Staphylococcus aureus detection test, Xpert MRSA.
In a separate agreement, Cepheid also will supply the Veterans Integrated Services Network 12, also called the Great Lakes Health Care System, with the Xpert MRSA tests and the GeneXpert systems. The company said VISN 12 plans to conduct around 40,000 of the MRSA tests each year to help manage infection control.
Financial terms of the agreements were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more